Connect Biopharma Holdings Limited Increase (Decrease) in Other Noncurrent Assets
Connect Biopharma Holdings Limited (CNTB) reported Increase (Decrease) in Other Noncurrent Assets of -$3.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-12
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$2.00K, a 122.22% decline year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $599.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$1.00K, a 103.23% decline year-over-year.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for fiscal 2025 was $605.00K.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00.
- Connect Biopharma Holdings Limited increase (decrease) in other noncurrent assets for fiscal 2023 was -$238.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.00K 10-Q · filed 2026-08-12 | $596.00K derived: sum of 3 quarters · filed 2026-08-12 | $595.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-12 | $597.00K derived: sum of 2 quarters · filed 2026-05-12 | $596.00K derived: sum of 3 quarters · filed 2026-05-12 | $594.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $598.00K derived: sum of 2 quarters · filed 2026-03-31 | $596.00K derived: sum of 3 quarters · filed 2026-08-12 | $605.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.00K derived: sum of 2 quarters · filed 2026-08-12 | $6.00K 10-Q · filed 2025-11-12 | -$92.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $7.00K 10-Q · filed 2026-08-12 | -$91.00K derived: sum of 3 quarters · filed 2026-08-12 | -$60.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $9.00K 10-Q · filed 2026-05-12 | -$89.00K derived: sum of 2 quarters · filed 2026-05-12 | -$58.00K derived: sum of 3 quarters · filed 2026-05-12 | $8.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$67.00K derived: sum of 2 quarters · filed 2026-03-31 | -$1.00K derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $97.00K derived: sum of 2 quarters · filed 2025-11-12 | $98.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $67.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$238.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |